Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

The 1H NMR serum metabolomics response to a two meal challenge: a cross-over dietary intervention study in healthy human volunteers.

Rådjursöga M, Lindqvist HM, Pedersen A, Karlsson GB, Malmodin D, Brunius C, Ellegård L, Winkvist A.

Nutr J. 2019 Apr 8;18(1):25. doi: 10.1186/s12937-019-0446-2.

2.

Metabolic profiles from two different breakfast meals characterized by 1H NMR-based metabolomics.

Rådjursöga M, Karlsson GB, Lindqvist HM, Pedersen A, Persson C, Pinto RC, Ellegård L, Winkvist A.

Food Chem. 2017 Sep 15;231:267-274. doi: 10.1016/j.foodchem.2017.03.142. Epub 2017 Mar 27.

PMID:
28450006
3.

Nuclear Magnetic Resonance Structure and Mutational Analysis of the Lactococcin A Immunity Protein.

Kristiansen PE, Persson C, Fuochi V, Pedersen A, Karlsson GB, Nissen-Meyer J, Oppegård C.

Biochemistry. 2016 Nov 15;55(45):6250-6257. Epub 2016 Nov 3.

PMID:
27808503
4.

A mutation in POLE predisposing to a multi-tumour phenotype.

Rohlin A, Zagoras T, Nilsson S, Lundstam U, Wahlström J, Hultén L, Martinsson T, Karlsson GB, Nordling M.

Int J Oncol. 2014 Jul;45(1):77-81. doi: 10.3892/ijo.2014.2410. Epub 2014 Apr 29.

5.

Proton-translocating transhydrogenase: an update of unsolved and controversial issues.

Pedersen A, Karlsson GB, Rydström J.

J Bioenerg Biomembr. 2008 Oct;40(5):463-73. doi: 10.1007/s10863-008-9170-x. Epub 2008 Oct 30. Review.

PMID:
18972197
6.

Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1.

Nordström EK, Forsell MN, Barnfield C, Bonin E, Hanke T, Sundström M, Karlsson GB, Liljeström P.

J Gen Virol. 2005 Feb;86(Pt 2):349-54.

PMID:
15659754
7.

Activation of p53 by scaffold-stabilised expression of Mdm2-binding peptides: visualisation of reporter gene induction at the single-cell level.

Karlsson GB, Jensen A, Stevenson LF, Woods YL, Lane DP, Sørensen MS.

Br J Cancer. 2004 Oct 18;91(8):1488-94.

8.
9.

Live viral vectors: Semliki Forest virus.

Karlsson GB, Liljeström P.

Methods Mol Med. 2003;87:69-82. No abstract available.

PMID:
12958450
10.

Determinants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivo.

Etemad-Moghadam B, Sun Y, Nicholson EK, Karlsson GB, Schenten D, Sodroski J.

J Virol. 1999 Oct;73(10):8873-9.

11.

Effects of soluble CD4 on simian immunodeficiency virus infection of CD4-positive and CD4-negative cells.

Schenten D, Marcon L, Karlsson GB, Parolin C, Kodama T, Gerard N, Sodroski J.

J Virol. 1999 Jul;73(7):5373-80.

12.

Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.

Reimann KA, Watson A, Dailey PJ, Lin W, Lord CI, Steenbeke TD, Parker RA, Axthelm MK, Karlsson GB.

Virology. 1999 Mar 30;256(1):15-21.

13.

Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2).

Cayabyab M, Karlsson GB, Etemad-Moghadam BA, Hofmann W, Steenbeke T, Halloran M, Fanton JW, Axthelm MK, Letvin NL, Sodroski JG.

J Virol. 1999 Feb;73(2):976-84.

14.

The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques.

Karlsson GB, Halloran M, Schenten D, Lee J, Racz P, Tenner-Racz K, Manola J, Gelman R, Etemad-Moghadam B, Desjardins E, Wyatt R, Gerard NP, Marcon L, Margolin D, Fanton J, Axthelm MK, Letvin NL, Sodroski J.

J Exp Med. 1998 Sep 21;188(6):1159-71.

15.

Characterization of simian-human immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeys.

Etemad-Moghadam B, Karlsson GB, Halloran M, Sun Y, Schenten D, Fernandes M, Letvin NL, Sodroski J.

J Virol. 1998 Oct;72(10):8437-45.

16.

Immunoglobulin V(H) usage during primary infection of rhesus monkeys with chimeric simian-human immunodeficiency viruses.

Margolin DH, Reimann KA, Sodroski J, Karlsson GB, Tenner-Racz K, Racz P, Letvin NL.

J Virol. 1997 Nov;71(11):8582-91.

17.

Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys.

Karlsson GB, Halloran M, Li J, Park IW, Gomila R, Reimann KA, Axthelm MK, Iliff SA, Letvin NL, Sodroski J.

J Virol. 1997 Jun;71(6):4218-25.

20.
21.
22.

The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.

Fischer PB, Collin M, Karlsson GB, James W, Butters TD, Davis SJ, Gordon S, Dwek RA, Platt FM.

J Virol. 1995 Sep;69(9):5791-7.

23.

N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing.

Platt FM, Neises GR, Karlsson GB, Dwek RA, Butters TD.

J Biol Chem. 1994 Oct 28;269(43):27108-14.

24.

Effects of the imino sugar N-butyldeoxynojirimycin on the N-glycosylation of recombinant gp120.

Karlsson GB, Butters TD, Dwek RA, Platt FM.

J Biol Chem. 1993 Jan 5;268(1):570-6.

25.

Modulation of cell-surface transferrin receptor by the imino sugar N-butyldeoxynojirimycin.

Platt FM, Karlsson GB, Jacob GS.

Eur J Biochem. 1992 Aug 15;208(1):187-93.

27.

[Microbreaks preventing musculoskeletal disorders].

Karlsson GB, Adle B, Löfgren B, Sundström I.

Lakartidningen. 1988 Oct 19;85(42):3463-4. Swedish. No abstract available.

PMID:
3199978
28.

Function of thioredoxin in oxidoreductions and as a subunit of phage-T7 deoxyribonucleic acid polymerase.

Holmgren A, Karlsson GB.

Biochem Soc Trans. 1978;6(1):50-2. No abstract available.

PMID:
346416

Supplemental Content

Loading ...
Support Center